The company procures raw materials, sub-assemblies, components, and other supplies from multiple suppliers both in the United States and internationally. Most raw materials and supplies are sourced from several suppliers in adequate quantities. The company maintains long-term supply contracts for certain materials that have limited suppliers or are single-sourced in specific regions, notably ethylene oxide (EO) and radioisotope cobalt-60 (cobalt-60), which are essential for AST operations. To reduce supply risk for cobalt-60, the company is expanding its irradiation processing capacity using accelerator-based technologies.
Steris Plc's Comment on Supply Chain
The company procures raw materials, sub-assemblies, components, and other supplies from multiple suppliers both in the United States and internationally. Most raw materials and supplies are sourced from several suppliers in adequate quantities. The company maintains long-term supply contracts for certain materials that have limited suppliers or are single-sourced in specific regions, notably ethylene oxide (EO) and radioisotope cobalt-60 (cobalt-60), which are essential for AST operations. To reduce supply risk for cobalt-60, the company is expanding its irradiation processing capacity using accelerator-based technologies.
Sources:
Steris Plc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Steris Plc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
